Search

everythinglearnresearchcommunity

for

Search:↓

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Treating gastrointestinal issues can reduce rosacea flares, and treating rosacea can lower gastrointestinal problems.

A new minoxidil regimen improved hair loss in a lupus patient.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Family caregivers take longer to fall asleep and have more sleep disturbances, which may contribute to their health problems.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Head and neck melanoma cases rose by 51.1% in young males aged 15-39 from 1995 to 2014.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

AMH is a promising biomarker for diagnosing PCOS.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Improving the scalp's barrier function can help reduce dandruff and maintain scalp health.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Women with PCOS have higher body fat and worse insulin resistance and lipid profiles.

HS patients rarely see dermatologists, often get opiates, and need better care.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Tamsulosin and finasteride have similar effects on blood sugar control in men with type 2 diabetes.